DANIEL ERNESTO
CASTELLANO GAUNA

Profesor asociado

Foto de DANIEL ERNESTO

Foto de Hospital Universitario Virgen Macarena

Hospital Universitario Virgen Macarena

Sevilla, España

Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario Virgen Macarena (5)

2022

Molecular Biomarkers of Prognosis in Advanced Renal Cell Carcinoma Patients Treated With Pazopanib Plus Interferon Alpha (INF-2A) in a Phase I/II Study by the Spanish Oncology Genitourinary Group
Clinical Genitourinary Cancer, Vol. 20, Núm. 4, pp. 388.e1-388.e10

2016

Randomized placebo controlled phase II trial (MAJA): Efficacy results of maintenance vinflunine after cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). SOGUG 2011-02
Annals of Oncology, Vol. 27, pp. vi277

2015

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: A retrospective cross-sectional analysis
BMC Cancer, Vol. 15, Núm. 1

2013

Erratum: The role of pharmacogenomics in metastatic renal cell carcinoma (Cancer and Metastasis Reviews (2012) 31:SUPPL. 1 (S29-S32) DOI: 10.1007/s10555-012-9356-x)
Cancer and Metastasis Reviews

2012

The role of pharmacogenomics in metastatic renal cell carcinoma
Cancer and Metastasis Reviews, Vol. 31, pp. S29-S32